Surrozen, Inc./DE Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted
Surrozen, Inc./DE (SRZN) reported Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Earnings Per Share
us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted · last filed 2026-08-06
- Surrozen, Inc./DE undistributed earnings (loss) allocated to participating securities, diluted for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Surrozen, Inc./DE undistributed earnings (loss) allocated to participating securities, diluted for the quarter ending 2025-06-30 was $17.94M.
| Period end | Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted 3 month | Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted 6 month |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 |
| 2025-06-30 | $17.94M 10-Q · filed 2026-08-06 | $7.57M 10-Q · filed 2026-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |